Skip to content

Drug interactions

Tacrolimus + Vilanterol / fluticasone furoate inhaled

Severity: Moderate

Tacrolimus and Vilanterol / fluticasone furoate inhaled: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tacrolimus may prolong the QT interval, and vilanterol, a long-acting beta-agonist, can add cardiovascular effects. Inhaled systemic exposure is low, so the clinical effect is usually limited, but patients with cardiac risk factors may be affected. Fluticasone furoate is a CYP3A4 substrate, though tacrolimus is not a significant inhibitor.

What this interaction means in plain words

Tacrolimus and Vilanterol / fluticasone furoate inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation and beta-adrenergic cardiac effects, with possible beta-agonist-related hypokalemia.

What to do

Monitor ECG and serum potassium and magnesium in patients with cardiac risk factors or other QT-prolonging drugs. Counsel patients to report palpitations or syncope.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tacrolimus and Vilanterol / fluticasone furoate inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tacrolimus with Vilanterol / fluticasone furoate inhaled?

MediHelp rates the interaction as moderate. Tacrolimus and Vilanterol / fluticasone furoate inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tacrolimus may prolong the QT interval, and vilanterol, a long-acting beta-agonist, can add cardiovascular effects. Inhaled systemic exposure is low, so the clinical effect is usually limited, but patients with cardiac risk factors may be affected. Fluticasone furoate is a CYP3A4 substrate, though tacrolimus is not a significant inhibitor.

How serious is the interaction between Tacrolimus and Vilanterol / fluticasone furoate inhaled?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium and magnesium in patients with cardiac risk factors or other QT-prolonging drugs. Counsel patients to report palpitations or syncope.

What other medicines interact with Tacrolimus?

MediHelp also lists interactions of Tacrolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Cidofovir. The full list is on the Tacrolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in